ANTAZOLINE
UNII DHA8014SS1

Substance Identification & Data

This profile provides standardized clinical and technical data for Antazoline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DHA8014SS1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 91-75-8 and the RxNorm Concept ID (RxCUI) 865. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DHA8014SS1

CAS Registry Number

91-75-8

RxNorm Concept ID

865

Detailed Substance Profile

Preferred Name

ANTAZOLINE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

DHA8014SS1

The specific atomic composition represented as a molecular structure string.

InChIKey

C17H19N3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

REYFJDPCWQRWAA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C61638

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

2200

Unique identification number in the NCBI database of chemical substances.

INN ID

1142

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1ccc(cc1)CN(CC2=NCCN2)c3ccccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Antazoline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.